我国疫苗伤害救济的路径选择和制度构想  

Route Selection and System Conception of China's Vaccine Injury Remedy

作　　者：刘洪华[1] 

机构地区：[1]韶关学院法学院

出　　处：《法学评论》2015年第1期136-143,共8页Law Review

摘　　要：疫苗伤害救济事关公共安全。我国疫苗伤害救济制度存在救济范围窄、补偿标准不明确、补偿程序复杂以及因果关系认定过于严格等问题。美国和德国分别代表着直接救济和侵权救济模式。两者各有优劣。我国应当采取直接救济模式,但辅之以追究相关责任人侵权责任。救济应当不问过错,构建救济基金制度,完善救济程序,实现快速、便捷、确定和慷慨救济的目标。Vaccine injury relief relates to public safety. China＇s vaccine injury relief system has some problems：the appli- cation scope of the state compensation is too narrow, the compensation standards are undefined, the compensation procedures are complex and the causality is too strict. The USA and Germany respectively take modes of direct relief and tort relief. The two modes both have their pros and cons. China should adopt the direct relief assisted by perusing the tort liability of the re- sponsible persons. The relief should be made by no--fault. A relief fund system should be constructed and the relief procedure should be perfected, so that it can provide the victims a rapid, convenient, definite and generous relief.

关 键 词：疫苗伤害 预防接种 救济 补偿 

分 类 号：D922.16[政治法律—宪法学与行政法学]